home / stock / pfe / pfe news


PFE News and Press, Pfizer Inc. From 06/27/24

Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...

PFE - Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and epidemiological data showing that the JN.1-adapted monovalent COVID-19 vaccine generates an improved ...

PFE - Dividend Harvesting Portfolio Week 172: $17,300 Allocated, $1,540.02 In Projected Dividends

2024-06-27 09:00:00 ET Summary Markets hit new highs with Nasdaq up 0.08% and S&P 500 up 0.68%. Dividend Harvesting Portfolio adds $89.68 in profitability, projecting future growth. Portfolio generates $1,540.02 in forward dividend income, focusing on diversification and i...

PFE - Dividend Harvesting Portfolio Week 173: $17,300 Allocated, $1,540.02 In Projected Dividends

2024-06-27 09:00:00 ET Summary Markets hit new highs, with Nasdaq up 0.08% and S&P 500 up 0.68%. Dividend Harvesting Portfolio adds $89.68 in profitability, projecting future growth. Portfolio generates $1,540.02 in forward dividend income, focusing on diversification and ...

PFE - 2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

2024-06-27 04:37:00 ET The benchmark S&P 500 index is up an exciting 25.8% over the past year, but many of its components haven't participated in the gains. Nvidia and other members of the " Magnificent Seven " have been hogging all the attention. While the most popular ...

PFE - 2 Stocks Down More Than 30% to Buy Right Now

2024-06-27 04:27:00 ET The S&P 500 is soaring as this bull market roars on, but some stocks, even those that have rebounded in recent times, still are trading at much lower levels than in the past. In fact, two stocks that have dropped in the double digits over the past few years ar...

PFE - GSK, Pfizer decline as CDC advisors recommend narrower age range for RSV shots

2024-06-26 16:38:07 ET More on GSK, Pfizer Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs Pfizer: Seriously Undervalued At Peak Pessimism Pfizer Stock: The Reversal Should Keep Going Pfizer CEO reveals new weight loss drug mechanism in...

PFE - Pfizer Declares Third-Quarter 2024 Dividend

Board of Directors approves quarterly cash dividend of $0.42 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the company’s common stock, payable September 3, 2024, to holders of the Common Stock of re...

PFE - Gain rotation out of semis is feeding into other parts of the market - Argus

2024-06-26 12:31:01 ET Volume away from semiconductor ETFs’ ( SMH ), ( SEMI ), ( NASDAQ: SOXX ) overbought conditions could mean some long-term bullishness with other parts of the market seeing gains, according to an Argus Research Market Movers note.... Read th...

PFE - Moderna dips after latest RSV vaccine efficacy data

2024-06-26 11:29:54 ET More on Moderna Moment Of Truth Approaches For Moderna's RSV Vaccine Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript) ...

PFE - Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.

2024-06-26 10:06:00 ET When one player stumbles in a high-stakes competition, it's often to the glee of the other contenders. In mid-June, Pfizer 's (NYSE: PFE) gene-therapy candidate to treat Duchenne muscular dystrophy (DMD) didn't hit the mark in a late-stage clinical trial; it'd...

Previous 10 Next 10